INCY - Incyte Corp.
IEX Last Trade
65.66
-0.250 -0.381%
Share volume: 2,548,261
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$65.91
-0.25
-0.38%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-01 | 2023-02-07 | 2023-05-02 | 2023-08-01 | 2023-10-31 | 2024-02-13 | 2024-04-30 | 2024-07-30 | |
| Assets | |||||||||
| Total Assets | 5.510 B | 5.841 B | 5.798 B | 6.208 B | 6.388 B | 6.782 B | 7.136 B | 4.662 B | |
| Current Assets | 3.821 B | 4.093 B | 3.972 B | 4.264 B | 4.403 B | 4.645 B | 4.849 B | 2.567 B | |
| Inventories | 45.869 M | 41.995 M | 40.876 M | 35.937 M | 57.200 M | 62.972 M | 63.642 M | 100.704 M | |
| Other Current Assets | 179.932 M | 167.011 M | 194.257 M | 167.136 M | 171.749 M | 182.830 M | 189.235 M | 207.956 M | |
| Short Term Investments | 179.932 M | 167.011 M | 194.257 M | 167.136 M | 171.749 M | 182.830 M | 189.235 M | 207.956 M | |
| Total Receivables | 618.188 M | 644.879 M | 623.788 M | 637.994 M | 657.263 M | 743.557 M | 745.526 M | 739.050 M | |
| Current Cash | 2.977 B | 3.239 B | 3.113 B | 3.423 B | 3.516 B | 3.656 B | 3.851 B | 1.519 B | |
| Total Non-current Assets | 1.689 B | 1.748 B | 1.826 B | 1.944 B | 1.986 B | 2.137 B | 2.287 B | 2.095 B | |
| Property Plant Equipment | 715.733 M | 715.999 M | 741.701 M | 749.352 M | 733.046 M | 751.513 M | 719.999 M | 762.009 M | |
| Other Assets | 105.609 M | 130.697 M | 163.257 M | 199.385 M | 247.921 M | 284.607 M | 337.225 M | 302.720 M | |
| Intangible Assets | 134.603 M | 129.219 M | 140.658 M | 134.954 M | 129.249 M | 123.545 M | 117.841 M | 113.536 M | |
| Goodwill | 155.593 M | 155.593 M | 155.593 M | 155.593 M | 155.593 M | 155.593 M | 155.593 M | 155.593 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 5.510 B | 5.841 B | 5.798 B | 6.208 B | 6.388 B | 6.782 B | 7.136 B | 4.662 B | |
| Total liabilities | 1.284 B | 1.471 B | 1.335 B | 1.468 B | 1.457 B | 1.592 B | 1.741 B | 1.665 B | |
| Total current liabilities | 1.007 B | 1.157 B | 1.006 B | 1.119 B | 1.125 B | 1.240 B | 1.396 B | 1.337 B | |
| Accounts Payable | 163.175 M | 277.546 M | 55.633 M | 155.538 M | 139.411 M | 109.601 M | 164.238 M | 148.174 M | |
| Other liabilities | 246.491 M | 283.705 M | 299.245 M | 319.303 M | 303.253 M | 322.729 M | 315.947 M | 298.944 M | |
| Current long term debt | 3.112 M | 3.179 M | 3.149 M | 3.166 M | 3.064 M | 3.439 M | 3.678 M | 3.874 M | |
| Long term debt | 30.476 M | 30.083 M | 29.699 M | 29.491 M | 28.859 M | 29.162 M | 28.934 M | 28.745 M | |
| Other liabilities | 246.491 M | 283.705 M | 299.245 M | 319.303 M | 303.253 M | 322.729 M | 315.947 M | 298.944 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.227 B | 4.370 B | 4.463 B | 4.741 B | 4.931 B | 5.190 B | 5.394 B | 2.997 B | |
| Common stock | 222.415 M | 222.615 M | 222.960 M | 223.248 M | 224.078 M | 224.226 M | 224.484 M | 218.175 M | |
| Retained earnings | -465.675 M | -437.214 M | -415.511 M | -211.963 M | -40.694 M | 160.385 M | 329.933 M | -1.380 B |